Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Promising new Alzheimer’s drug candidate developed by international research team
A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of Alzheimer’s disease.
Promising 'first' in Alzheimer's drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on both major aggregation-promoting 'hotspots' of the Tau protein in the brain -- a key driver of neurodegeneration.
Alzheimer's 'First' Achieved With Drug That Hits Hotspots
The compound, called
RI-AG03
, is a novel peptide inhibitor—a short chain of amino acids designed to block the activity of specific proteins. In fruit fly models and lab experiments on human ...
‘One-of-a-kind’ new Alzheimer’s drug shows promise: ‘An exciting development’
Researchers say they have sparked an “exciting” breakthrough in treating Alzheimer’s disease by developing a drug to prevent the build-up of toxic proteins in the brain. “This research is taking promising steps toward a new one-of-a-kind therapy which targets tau,
Hosted on MSN
1d
Alzheimer's disease could be stopped in its tracks by new drug with potential to 'prevent progression'
This drug has the potential to be more targeted than others currently being studied, and we hope it will result in fewer ...
studyfinds
2h
Scientists develop potent weapon against Alzheimer’s protein clumps
Scientists have developed a novel peptide that could potentially revolutionize the treatment of Alzheimer's disease and other neurodegenerative disorders known as tauopathies.
ScienceAlert on MSN
2d
Breakthrough Alzheimer's Drug Targets Key 'Hotspots' to Suppress Toxic Tangles
The drug is RI-AG03, and it's a peptide inhibitor (a blocker of proteins). In tests on fruit flies and human cells, it has ...
6d
Alzheimer’s Game Changer: Dual-Action Drug Attacks Disease at Its Core
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
Neuroscience News
5d
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
BioWorld
5d
RI-AG03 targets main promoters of tau protein aggregation at once
The increasing knowledge on how protein tau is organized in live cells has shown that the protein forms nanometer-sized ...
the Westmorland Gazette
10h
Alzheimer's treatment breakthrough for Kendal-born doctor
Dr Anthony Aggidis, a former Postdoctoral Research Associate at Lancaster University, led the study of the drug RI-AG03.
protothema.gr
2d
Innovative Drug for Alzheimer’s Disease Brings New Hope for Treatment
A new drug targeting Tau protein shows promise in preventing its accumulation, potentially leading to more effective ...
6d
on MSN
Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback